Clinical Trial Update: Detection of Reduced Left Ventricular Ejection Fraction With Three-Lead ECG Using Artificial Intelligence

View source ↗

Summary

A clinical trial by Eko Devices is evaluating AI-assisted detection of reduced left ventricular ejection fraction using a three-lead ECG, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Eko Devices, Inc. | Conditions: Low Ejection Fraction | Status: RECRUITING